.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Accenture
AstraZeneca
Fuji
McKesson
UBS
Fish and Richardson
Cantor Fitzgerald
Julphar
Merck

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,795,312

« Back to Dashboard

Which drugs does patent 7,795,312 protect, and when does it expire?


Patent 7,795,312 protects AMITIZA and is included in one NDA. There has been one Paragraph IV challenge on Amitiza.

This patent has twenty-one patent family members in fourteen countries.

Summary for Patent: 7,795,312

Title:Method for treating abdominal discomfort
Abstract:A method for treating irritable bowel syndrome in a mammalian subject includes administering an effective amount of 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E.sub.1 or 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E.sub.1, or a salt, ether, ester or amide thereof, to the subject. A method for treating abdominal discomfort associated with irritable bowel syndrome in a mammalian subject includes administering an effective amount of 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E.sub.1 or 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E.sub.1, or a salt, ether, ester or amide thereof, to the subject.
Inventor(s): Ueno; Ryuji (Montgomery, MD), Kuno; Sachiko (Montgomery, MD)
Assignee: Sucampo AG (Zug, CH)
Application Number:10/745,689
Patent Claim Types:
see list of patent claims
Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Sucampo Pharma LlcAMITIZAlubiprostoneCAPSULE;ORAL021908-002Apr 29, 2008RXYesNo► Subscribe► Subscribe► SubscribeMETHOD FOR TREATING IRRITABLE BOWEL SYNDROME AND METHOD FOR TREATING ABDOMINAL DISCOMFORT ASSOCIATED WITH IRRITABLE BOWEL SYNDROME
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,795,312

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway335441► Subscribe
Norway20053623► Subscribe
MexicoPA05006981► Subscribe
South Korea20120045051► Subscribe
South Korea101164838► Subscribe
South Korea20050086950► Subscribe
Japan2012031202► Subscribe
Japan4889219► Subscribe
Japan2006513232► Subscribe
Spain2591252► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Daiichi Sankyo
Moodys
UBS
Johnson and Johnson
Argus Health
QuintilesIMS
Dow
Chinese Patent Office
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot